The 9th Annual International Symposium of Drug Delivery Systems

Scientific Program

Program

Time: July 12-July 14, 2023

Venue: Amsterdam, the Netherlands

Registration
Time: 10:00-21:00, July 11, 2023 (Tuesday); Place: In Front of Rembrandt Room, Ground Floor, Holiday Inn Amsterdam Arena Towers
Opening Ceremony
Time: 09:00-09:10, July 12, 2023 (Wednesday); Place: Rembrandt Room, Ground Floor, Holiday Inn Amsterdam Arena Towers
Keynote Forum (Sponsored by Wyatt Technology)
Time: 09:10-12:10, July 12, 2023 (Wednesday); Place: Rembrandt Room, Ground Floor, Holiday Inn Amsterdam Arena Towers

Moderator	*Dr. Matthew He,* Professor, Halmos College of Arts and Sciences, Nova Southeastern University, USA

09:10-09:15	Chair’s Introduction
09:15-09:40	*Title:* Advanced Cellular Models and Future Applications *Dr. Stefan Platz,* SVP & Global Head Clinical Pharmacology & Safety Sciences, AstraZeneca, UK
09:40-10:05	*Title:* The Academia-CRO Tandem: The Drug Discovery Engine of the Future? *Dr. Luc Van Hijfte,* Senior VP Drug Discovery, Symeres B.V., the Netherlands
10:05-10:30	*Title:* From Informatics to Intelligence: Bioinformatics, Bioengineering, And Brain Science *Dr. Matthew He,* Professor, Halmos College of Arts and Sciences, Nova Southeastern University, USA
10:30-10:55	*Title:* The Role of ABC Membrane Transporters in Personalized Diagnostics and Drug Treatment *Dr. Balazs Sarkadi,* Professor Emeritus, Research Centre for Natural Sciences, Institute of Enzymology, Hungary
10:55-11:20	*Title:* Nanoparticles for Gene and Drug Delivery: Applying Light Scattering to Screening and Characterization *Dr. Roger Scherrers,* Head of Analytical Service, Water, Wyatt Technology Division, Germany
11:20-11:45	*Title:* Protein-DNA Recognition and Target Location Studied by NMR Spectroscopy *Dr. Robert Kaptein,* Emeritus Professor, Bijvoet Center for Biomolecular Research, Utrecht University, The Netherlands
11:45-12:10	*Title:* Building Better Treatments for Type 1 Diabetes Based on Understanding Human Pathogenesis *Dr. Matthias von Herrath,* Scientific Director of the Diabetes Research Institute, University of Miami School of Medicine; Vice President, Novo Nordisk, USA (Video)
SDDS 01: Novel Drug Delivery Technologies, Systems and Devices
Time: 13:30-16:30, July 12, 2023 (Wednesday) ; Place: Rembrandt 5, Ground Floor, Holiday Inn Amsterdam Arena Towers

Chair	*Dr. David R. Friend*, Chief Scientific Officer, Dare Bioscience, Inc., USA

13:30-13:35	Chair’s Introduction
13:35-13:55	*Title:* GalAhead™: A Proprietary GalNAc-RNAi Therapeutic Platform to Downregulate Single and Multiple Genes *Dr. Jim Weterings*, Senior Director & Head of Technology Development, Sirnaomics, USA
13:55-14:15	*Title:* Vaginal Rings: Expanding Drug Delivery Options for Women *Dr. David R. Friend*, Chief Scientific Officer, Dare Bioscience, Inc., USA
14:15-14:35	*Title:* Dendritic Prodrugs: A Novel Nanotech Approach to Combat Opioid Crisis *Dr. Sam Dylan More,* CEO & Head of R&D, Dendropharm GmbH, Germany
14:35-14:55	*Title:* Optimization of in Situ Gel-forming Loading Chlorhexidine Digluconate-encapsulated Polymeric Nanoparticles Using Design of Experiment for Treatment Periodontitis *Dr. Mont Kumpugdee-Vollrath,* Professor, Berliner Hochschule fur Technik - University of Applied Sciences, Germany
14:55-15:15	*Title:* Innovative autoinjector concept for the application of complex biologics *Dr. Sigrid Saaler-Reinhardt,* Senior Director Biotechnology & Combination Products, Midas Pharma GmbH, Germany
15:15-15:30	Coffee Break
15:30-15:50	*Title:* Application of Non-Invasive Imaging Techniques for the Assessment of Breath Actuated Inhalers Devices *Dr. Seamus D*. Murphy, Manager - Imaging Division, Oxford Lasers Ltd, UK
15:50-16:10	*Title:* Chemical and Physical Characterization Properties of Molded Glass *Dr. Nicola Favaro,* Lab Director, Stazione Sperimentale Vetro, Italy
16:10-16:30	*Title:* Simple Methods to Increase Hydrophilic Polyphenols Stability in Aqueous Solutions: Experimental and Theoretical Characterizations *Dr. Philippe-Henri Secretan,* Associate Professor, University Paris Saclay, France
SDDS 02: Latest Advances in Targeted Drug Delivery
Time: 08:30-12:20, July 13, 2023 (Thursday); Place: Rembrandt 5, Ground Floor, Holiday Inn Amsterdam Arena Towers

Chair	*Dr. Marta Venczel,* Head of Biopharmacy, Early Development Frankfurt, Sanofi, Germany
Co-Chair	*Dr. Daniel Gonzalez-Carter,* Senior Scientist/Research Fellow, Institute for Bioengineering of Catalonia (IBEC), Spain

08:30-08:35	Chair’s Introduction
08:35-08:55	*Title:* Design and Optimization of Small Molecule Drug Conjugates Targeting the Tumor Microenvironment *Dr. Hans-Georg Lerchen,* Chief Scientific Officer, Vincerx Pharma GmbH, Germany
08:55-09:15	*Title:* Biopharmaceutical Evaluation of Subcutaneously Injected Formulations *Dr. Marta Venczel,* Head of Biopharmacy, Early Development Frankfurt, Sanofi, Germany
09:15-09:35	*Title:* Drug Delivery Strategies for Topical Treatment of Skin and Wounds *Dr. Fiorenza Rancan,* Associate Professor, Charite - Berlin University of Medicine, Germany
09:35-09:55	*Title:* Generating Artificial Targets to Deliver Therapies Selectively to the Brain *Dr. Daniel Gonzalez-Carter,* Senior Scientist/Research Fellow, Institute for Bioengineering of Catalonia (IBEC), Spain
09:55-10:15	*Title:* Organophosphorus Nerve Agents Countermeasure: How and Why Cholinesterases Reactivators Have to Reach Also the Brain? *Dr. Pierre-Yves Renard*, Professor, University of Rouen Normandy, France
10:15-10:30	Coffee Break
10:30-10:50	*Title:* Phospholipid Ether Drug Conjugates; Cancer’s Achilles Heel *Dr. Jarrod Longcor,* Chief Operations Officer, Cellectar Biosciences Inc., USA
10:50-11:10	*Title:* Formulation and Characterization Studies of Transdermal Patches *Dr. Gulay Yelken Demirel,* RD Manager, Exeltis Pharmaceuticals, Turkey
11:10-11:30	*Title:* Topical Drug Delivery to the Posterior Segment of the Eye: Obstacles and Routes to Success *Dr. Thorsteinn Loftsson*, Professor Emeritus, University of Iceland, Iceland
11:30-12:00	*Title:* Treatment of Cerebral Malaria - Drug Delivery Aspects *Dr. Jacob Golenser,* Professor Emeritus, The Hebrew University of Jerusalem, Israel
12:00-12:20	*Title:* GnRH Peptide/Lipid Adjuvant Conjugate Vaccines for Veterinary Immunocastration Dr. *Istvan Toth*, Professor, School of Chemistry and Molecular Biosciences and School of Pharmacy, The University of Queensland, Australia
SDDS 03: New Materials and Carriers for Drug Delivery
Time: 08:30-10:15, July 14, 2023 (Friday) ; Place: Rembrandt 3, Ground Floor, Holiday Inn Amsterdam Arena Towers

Chair	*Dr. Steve Faraci,* CSO, Cyta Therapeutics, Inc., USA
Co-Chair	*Dr. Andreas Nixdorf*, Business Development Manager, SGS Institute Fresenius GmbH, Germany

08:30-08:35	Chair’s Introduction
08:35-08:55	*Title:* Stable Nanoemulsion for Delivery of Frankincense against InflammAging *Dr. Gabriele Blume,* CEO, Sopharcos Drug Delivery, Germany
08:55-09:15	*Title:* Functionalized Harmonic Nanoparticles for Bioimaging and NIR-Light Triggered Drug Delivery *Dr. Sandrine Gerber,* Professor, Ecole Polytechnique Federale de Lausanne, Switzerland
09:15-09:35	*Title:* Demonstrating Transformative Weight Loss in a Diet-Induced Obesity Animal Model Utilizing a Unique Nanoparticle Delivery System *Dr. Steve Faraci,* CSO, Cyta Therapeutics, Inc., USA
09:35-09:55	*Title:* Regulatory Requirements in Leachables Safety Evaluation of Packaging Materials and Drug Delivery Systems for Pharmaceuticals *Dr. Andreas Nixdorf*, Business Development Manager, SGS Institute Fresenius GmbH, Germany
09:55-10:15	*Title:* Analysis of Transport of Oral Vaccines with Gut Organoid Mucosal Model *Dr. Chenxu Yu,* Associate Professor, Iowa State University, USA